Literature DB >> 25399225

Mass lesion in a chest x-ray of a male adolescent. Round pneumonia.

Indira Madhavan1, Mekkattukunnel A Andrews.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25399225      PMCID: PMC4362131     

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


× No keyword cloud information.
Notice: Authors are encouraged to submit quizzes for possible publication in the Journal. These may be in any specialty, and should approximately follow the format used here (maximum of 2 figures). Please address any submissions to: Editor, Saudi Medical Journal, Prince Sultan Military Medical City, PO Box 7897, Riyadh 11159, Kingdom of Saudi Arabia. Tel. +966 (11) 4777714 Ext. 42846.

Mass lesion in a chest x-ray of a male adolescent

Clinical Presentation

A 16-year-old boy presented with history of fever and cough for 4 days. On examination he was febrile, tachypnoeic with a pulse rate of 90 beats/minute, and blood pressure of 110/70 mm Hg. Clinical examination of respiratory system showed central trachea with dull note on percussion, bronchial breath sound, and crepitations in the right infraclavicular area. Investigations showed hemoglobin of 13 gm/dL, white blood cell count of 14×109/L and platelet count of 200×109/L The sputum acid-fast bacilli was negative. The chest x-ray (CXR) showed a rounded opacity in the right upper zone with well-defined margin (). An image showing a rounded opacity with well-defined margin in the right upper zone (arrow). What is the diagnosis? What is the differential diagnosis? Round pneumonia. The differential diagnosis include bronchogenic cyst, lymphoma, carcinoid, hamartoma, granuloma, hydatid cyst, lung abscess, lipoid pneumonia, rheumatoid nodule, round atelectasis, fungal pneumonia, pulmonary pseudotumour, pleural fibroma, bronchial metastasis and bronchogenic carcinoma.

Discussion

Well-defined rounded opacities in CXR can be termed as pulmonary nodules or mass lesions, and the etiology can vary from benign to malignant causes.1 We report a case of mass lesion in CXR of an adolescent boy, which turned out to be a fully treatable infectious condition. The CT of the thorax and bronchoscopy was planned after a course of antibiotics, as his clinical features were consistent with pneumonia. He was treated with IV cefotaxime, and oral azithromycin as per national pneumonia guidelines for hospitalized non-ICU patients. The symptoms improved within one week, and CXR taken 2 weeks later showed good clearance of the lesion. Final diagnosis of round pneumonia was established. Round pneumonia represents an area of consolidation, seen as nodules or coin lesions in x-ray, commonly in the pediatric age group, but can rarely occur in adults.2 Well-defined round opacity is due to the confinement of infection to a small area as interalveolar communications, and collateral airways in children, especially below 8 years of age are not well developed. The lesion is not always round as it can be oval, or triangular. The ‘pores of Kohn and canal of Lambert’ are well-developed communications in adults, which allows lateral spread of infection resulting in lobar pneumonia. Round pneumonia in adult is usually due to developmental defect of intralveolar communication, or during delayed resolution of lobar pneumonia, where it can be termed as focal organizing pneumonia.3 Air bronchogram, which is present in 17% of CXR of round pneumonia clinches the diagnosis, but also seen in adenocarcinoma and bronchoalveolar carcinoma.4 A CT of the chest and positron emission tomography helps in differentiating benign from malignant lesions.5 According to the World Health Organization bulletin, India ranks highest in newer pneumonia cases in numbers annually.6 Streptococcus pneumoniae was isolated as the common pathogen in many case series of community acquired pneumonia from India, while mycoplasma pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae, and Haemophilus influenza are the other common organisms isolated, but no organisms were isolated in the available case reports of round pneumonia from India. Organism causing pneumonia was not isolated in our case, but common etiological agents reported worldwide in round pneumonia are Streptococcus pneumonia, Klebsiella pneumoniae, Coxiella Burnetii and Mycobacterium tuberculosis.1 Repetition of x-ray after a 2-3 weeks of antibiotic therapy can be carried out where good clearance of lesion confirms pneumonia. However, any lesion that does not resolve, or decrease in size with antibiotic therapy may necessitate further investigations such as bronchoscopy and biopsy. In conclusion, round pneumonia in adults can be suspected in round mass lesions with onset suggestive of infectious etiology. Good response to therapeutic intervention may confirm the diagnosis, however, lack of response may require further investigations.
  5 in total

1.  Round pneumonia in children.

Authors:  Solmaz Celebi; Mustafa Hacimustafaoglu
Journal:  Indian J Pediatr       Date:  2008-06-08       Impact factor: 1.967

2.  Diagnostic value of PET/CT in differentiating benign from malignant solitary pulmonary nodules.

Authors:  A Dalli; H Selimoglu Sen; M Coskunsel; H Komek; O Abakay; C Sergi; A Cetin Tanrikulu
Journal:  J BUON       Date:  2013 Oct-Dec       Impact factor: 2.533

3.  Round pneumonia in a 50-year-old man.

Authors:  Burke A Cunha; Arthur Gran; Jaime Simon
Journal:  Respir Care       Date:  2012-12-18       Impact factor: 2.258

Review 4.  Round pneumonia: a rare condition mimicking bronchogenic carcinoma. Case report and review of the literature.

Authors:  José Jesus de Peixoto Camargo; Spencer Marcantonio Camargo; Tiago Noguchi Machuca; Fabíola Adélia Perin
Journal:  Sao Paulo Med J       Date:  2008-07       Impact factor: 1.044

5.  Case of round pneumonia: pulmonary infarct and a rare situation that is similar with the lung cancer.

Authors:  Dilay Çimen; Emel Bulcun; Aydanur Ekici; Ömür Güngör; Mehmet Ekici
Journal:  Clin Respir J       Date:  2014-05-15       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.